ASHP releases statement on pharmacist’s role in clinical pharmacogenomics

Published: April 1st, 2015

Category: Stories

The American Society of Health System Pharmacists (ASHP) published a position statement on the pharmacist’s role in clinical pharmacogenomics in the April 2015 edition of the American Journal of Health-System Pharmacy. This statement was developed by the ASHP Section of Clinical Specialists and Scientists Section Advisory Group on Emerging Sciences.

Given that appropriate medication selection increasingly incorporates assessment of pharmacogenomic data, ASHP proposes the following responsibilities for pharmacists:

  • Advocating for rational and routine use of pharmacogenomic testing
  • Providing guidance on interpreting and returning pharmacogenomic test results
  • Optimizing drug therapy with consideration of pharmacogenomic data
  • Educating health professionals, patients, and the community on clinical pharmacogenomics
  • Participating in research initiatives that inform clinical pharmacogenomics applications

Based on these responsibilities, ASHP states that all pharmacists should be able to perform functions that require a basic understanding of pharmacogenomics, including recommending pharmacogenomic tests as appropriate, incorporating pharmacogenomic data into a patient’s care plan, and communicating and documenting pharmacogenomic-guided drug therapy recommendations.

ASHP also recognizes a need for pharmacists with specialized training or experience in pharmacogenomics. Additional functions that should be performed by these pharmacists include developing clinical decision support tools; creating processes for implementing pharmacogenomics services within an institution; developing patient-education strategies; serving on a specialized clinical pharmacogenomics service; developing advanced training opportunities for pharmacists in pharmacogenomics; and others.

Clinical Implications

This statement outlines a framework for pharmacists’ responsibilities and functions in pharmacogenomics. Education and training opportunities are increasing for pharmacists to expand their knowledge and skills in pharmacogenomics, including ASHP-accredited specialty residency training. In addition, education and practice resources are available online for pharmacists, including those through the PharmGKB, the Genetics and Genomics Competency Center (G2C2), and ASHP’s Emerging Sciences Resource Center for Pharmacogenomics.

Reference:

American Society of Health-System Pharmacists. ASHP statement on the pharmacist’s role in clinical pharmacogenomics. Am J Health-Syst Pharm. 2015;72:579–81.